GeneChip expression profiling identified OLFML2A as a potential therapeutic target in TNBC cells

BACKGROUND: An elevated level of olfactomedin-like-2A (OLFML2A) is unfavorable for female breast cancer patients. Patients with a high mRNA level of OLFML2A receive a poor prognosis. Therefore, we speculate that inhibiting the expression of this gene may be beneficial to breast cancer patients. We p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xiufei, Yang, Zimei, Xu, Chuchu, Yu, Qinghong, Wang, Mengqian, Song, Jiaqing, Wu, Chunyu, Chen, Mingcang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011253/
https://www.ncbi.nlm.nih.gov/pubmed/35433966
http://dx.doi.org/10.21037/atm-22-757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011253/
https://www.ncbi.nlm.nih.gov/pubmed/35433966
http://dx.doi.org/10.21037/atm-22-757

Ejemplares similares